Concepts (175)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Fibromyalgia | 14 | 2018 | 25 | 5.690 |
Why?
|
| Pain | 10 | 2014 | 288 | 1.830 |
Why?
|
| Exercise | 6 | 2014 | 672 | 1.670 |
Why?
|
| Osteoarthritis | 6 | 2012 | 79 | 1.540 |
Why?
|
| Pain Measurement | 16 | 2020 | 350 | 1.500 |
Why?
|
| Exercise Therapy | 5 | 2018 | 270 | 1.400 |
Why?
|
| European Continental Ancestry Group | 7 | 2009 | 1166 | 1.280 |
Why?
|
| African Americans | 7 | 2009 | 1425 | 1.060 |
Why?
|
| Depression | 7 | 2020 | 444 | 1.050 |
Why?
|
| Middle Aged | 35 | 2019 | 11817 | 1.050 |
Why?
|
| Arthroplasty, Replacement, Knee | 6 | 2019 | 89 | 1.040 |
Why?
|
| Treatment Outcome | 15 | 2019 | 3306 | 1.030 |
Why?
|
| Walking | 3 | 2016 | 209 | 0.980 |
Why?
|
| Arthroplasty, Replacement | 4 | 2009 | 17 | 0.910 |
Why?
|
| Osteoarthritis, Knee | 5 | 2019 | 90 | 0.790 |
Why?
|
| Female | 32 | 2019 | 19959 | 0.760 |
Why?
|
| Adult | 21 | 2018 | 9345 | 0.750 |
Why?
|
| Pain Threshold | 3 | 2018 | 92 | 0.750 |
Why?
|
| Male | 29 | 2019 | 19165 | 0.700 |
Why?
|
| Humans | 40 | 2020 | 32005 | 0.700 |
Why?
|
| Veterans | 6 | 2020 | 68 | 0.680 |
Why?
|
| Arthritis, Rheumatoid | 3 | 2017 | 40 | 0.660 |
Why?
|
| Osteoarthritis, Hip | 3 | 2009 | 15 | 0.650 |
Why?
|
| Motivation | 2 | 2010 | 112 | 0.610 |
Why?
|
| Connective Tissue Diseases | 1 | 2017 | 7 | 0.580 |
Why?
|
| Biological Therapy | 1 | 2017 | 20 | 0.570 |
Why?
|
| Autoimmune Diseases | 1 | 2017 | 48 | 0.560 |
Why?
|
| Exercise Test | 1 | 2016 | 227 | 0.510 |
Why?
|
| Metformin | 1 | 2015 | 22 | 0.510 |
Why?
|
| Activities of Daily Living | 2 | 2013 | 257 | 0.490 |
Why?
|
| Neuralgia | 1 | 2015 | 48 | 0.490 |
Why?
|
| Severity of Illness Index | 7 | 2018 | 881 | 0.480 |
Why?
|
| Analgesics, Opioid | 1 | 2016 | 232 | 0.470 |
Why?
|
| Aged | 17 | 2018 | 10301 | 0.460 |
Why?
|
| Health Status | 5 | 2018 | 399 | 0.460 |
Why?
|
| Postural Balance | 1 | 2016 | 182 | 0.460 |
Why?
|
| Cyclopropanes | 1 | 2013 | 19 | 0.450 |
Why?
|
| Serotonin Uptake Inhibitors | 1 | 2013 | 37 | 0.440 |
Why?
|
| Pesticides | 1 | 2016 | 199 | 0.440 |
Why?
|
| Depressive Disorder | 1 | 2013 | 75 | 0.440 |
Why?
|
| Occupational Exposure | 1 | 2016 | 232 | 0.430 |
Why?
|
| Transients and Migrants | 1 | 2016 | 290 | 0.420 |
Why?
|
| Emigrants and Immigrants | 1 | 2016 | 244 | 0.420 |
Why?
|
| Randomized Controlled Trials as Topic | 3 | 2018 | 510 | 0.410 |
Why?
|
| Antirheumatic Agents | 2 | 2017 | 29 | 0.410 |
Why?
|
| Interviews as Topic | 2 | 2010 | 263 | 0.400 |
Why?
|
| Disability Evaluation | 5 | 2015 | 240 | 0.390 |
Why?
|
| Diabetes Mellitus | 1 | 2015 | 411 | 0.390 |
Why?
|
| Multicenter Studies as Topic | 2 | 2018 | 105 | 0.390 |
Why?
|
| Adaptation, Psychological | 3 | 2019 | 138 | 0.390 |
Why?
|
| Interleukin-8 | 1 | 2011 | 26 | 0.390 |
Why?
|
| Chemokine CCL2 | 1 | 2011 | 48 | 0.380 |
Why?
|
| Hispanic Americans | 2 | 2016 | 940 | 0.380 |
Why?
|
| Reflex | 1 | 2010 | 15 | 0.370 |
Why?
|
| Health Care Costs | 1 | 2012 | 118 | 0.370 |
Why?
|
| Stress Disorders, Post-Traumatic | 3 | 2020 | 47 | 0.360 |
Why?
|
| Health Care Rationing | 1 | 2009 | 12 | 0.350 |
Why?
|
| Obesity | 1 | 2018 | 1175 | 0.350 |
Why?
|
| Antidepressive Agents | 1 | 2009 | 74 | 0.340 |
Why?
|
| Analgesics | 3 | 2015 | 109 | 0.330 |
Why?
|
| Arthroplasty, Replacement, Hip | 1 | 2009 | 50 | 0.320 |
Why?
|
| Patient Compliance | 1 | 2010 | 225 | 0.320 |
Why?
|
| Culture | 1 | 2008 | 41 | 0.300 |
Why?
|
| Arthroplasty | 1 | 2008 | 29 | 0.300 |
Why?
|
| Patient Satisfaction | 3 | 2017 | 240 | 0.300 |
Why?
|
| Physicians, Family | 1 | 2007 | 16 | 0.290 |
Why?
|
| Decision Making | 2 | 2007 | 195 | 0.280 |
Why?
|
| Persian Gulf Syndrome | 1 | 2006 | 1 | 0.280 |
Why?
|
| Gulf War | 1 | 2006 | 1 | 0.280 |
Why?
|
| Patient Care Management | 1 | 2006 | 18 | 0.270 |
Why?
|
| Quality of Life | 2 | 2017 | 946 | 0.260 |
Why?
|
| Attitude to Health | 1 | 2007 | 165 | 0.260 |
Why?
|
| Musculoskeletal Diseases | 1 | 2005 | 37 | 0.250 |
Why?
|
| Young Adult | 5 | 2015 | 2636 | 0.230 |
Why?
|
| Time Factors | 4 | 2013 | 2149 | 0.230 |
Why?
|
| Longitudinal Studies | 3 | 2020 | 767 | 0.230 |
Why?
|
| Cross-Sectional Studies | 6 | 2018 | 1531 | 0.230 |
Why?
|
| Clinical Competence | 1 | 2007 | 333 | 0.230 |
Why?
|
| Follow-Up Studies | 3 | 2018 | 2265 | 0.230 |
Why?
|
| Ethnic Groups | 1 | 2006 | 476 | 0.220 |
Why?
|
| Self Care | 2 | 2015 | 144 | 0.220 |
Why?
|
| Faith Healing | 1 | 2002 | 2 | 0.210 |
Why?
|
| Prospective Studies | 5 | 2020 | 2282 | 0.210 |
Why?
|
| Chronic Disease | 3 | 2009 | 406 | 0.190 |
Why?
|
| Arthralgia | 2 | 2019 | 33 | 0.190 |
Why?
|
| Adolescent | 3 | 2015 | 3539 | 0.190 |
Why?
|
| United States | 5 | 2018 | 3939 | 0.180 |
Why?
|
| Retrospective Studies | 3 | 2015 | 3509 | 0.170 |
Why?
|
| Pilot Projects | 2 | 2011 | 545 | 0.160 |
Why?
|
| Illness Behavior | 1 | 2018 | 2 | 0.160 |
Why?
|
| Counseling | 2 | 2010 | 97 | 0.160 |
Why?
|
| Comorbidity | 3 | 2014 | 566 | 0.160 |
Why?
|
| Research Design | 2 | 2010 | 313 | 0.160 |
Why?
|
| Attention | 1 | 2018 | 83 | 0.150 |
Why?
|
| Spondylitis, Ankylosing | 1 | 2017 | 4 | 0.140 |
Why?
|
| Self Efficacy | 1 | 2017 | 78 | 0.140 |
Why?
|
| Gout | 1 | 2017 | 14 | 0.140 |
Why?
|
| Vasculitis | 1 | 2017 | 24 | 0.140 |
Why?
|
| Arthritis, Psoriatic | 1 | 2017 | 25 | 0.140 |
Why?
|
| Patient Education as Topic | 1 | 2019 | 271 | 0.140 |
Why?
|
| Immunologic Factors | 1 | 2017 | 49 | 0.140 |
Why?
|
| Lupus Erythematosus, Systemic | 1 | 2017 | 148 | 0.130 |
Why?
|
| Biological Products | 1 | 2017 | 77 | 0.130 |
Why?
|
| Off-Label Use | 1 | 2015 | 12 | 0.130 |
Why?
|
| Outpatients | 2 | 2005 | 57 | 0.130 |
Why?
|
| Antibodies, Monoclonal | 1 | 2017 | 246 | 0.120 |
Why?
|
| Multivariate Analysis | 2 | 2007 | 684 | 0.120 |
Why?
|
| Body Mass Index | 1 | 2018 | 923 | 0.120 |
Why?
|
| Hypoglycemic Agents | 1 | 2015 | 181 | 0.110 |
Why?
|
| Case-Control Studies | 1 | 2016 | 898 | 0.110 |
Why?
|
| Afghan Campaign 2001- | 3 | 2020 | 14 | 0.110 |
Why?
|
| Research | 1 | 2013 | 74 | 0.110 |
Why?
|
| Feasibility Studies | 1 | 2013 | 293 | 0.100 |
Why?
|
| Double-Blind Method | 1 | 2013 | 525 | 0.100 |
Why?
|
| Physical Therapy Modalities | 1 | 2012 | 64 | 0.100 |
Why?
|
| Insurance Claim Review | 1 | 2012 | 27 | 0.100 |
Why?
|
| North Carolina | 1 | 2016 | 1514 | 0.100 |
Why?
|
| Electromyography | 1 | 2010 | 59 | 0.090 |
Why?
|
| Sural Nerve | 1 | 2010 | 28 | 0.090 |
Why?
|
| Electric Stimulation | 1 | 2010 | 104 | 0.090 |
Why?
|
| Clinical Protocols | 1 | 2010 | 97 | 0.090 |
Why?
|
| Telephone | 1 | 2010 | 59 | 0.090 |
Why?
|
| Statistics, Nonparametric | 1 | 2010 | 130 | 0.090 |
Why?
|
| Indiana | 1 | 2009 | 26 | 0.090 |
Why?
|
| Prejudice | 1 | 2009 | 50 | 0.090 |
Why?
|
| Guideline Adherence | 1 | 2010 | 119 | 0.090 |
Why?
|
| Linear Models | 1 | 2010 | 447 | 0.080 |
Why?
|
| Fear | 1 | 2009 | 48 | 0.080 |
Why?
|
| Decision Support Techniques | 1 | 2010 | 128 | 0.080 |
Why?
|
| Health Behavior | 1 | 2010 | 232 | 0.080 |
Why?
|
| Aromatase Inhibitors | 1 | 2007 | 9 | 0.080 |
Why?
|
| Epidemiologic Methods | 1 | 2007 | 24 | 0.070 |
Why?
|
| Muscular Diseases | 1 | 2007 | 22 | 0.070 |
Why?
|
| Joint Diseases | 1 | 2007 | 37 | 0.070 |
Why?
|
| Logistic Models | 1 | 2009 | 781 | 0.070 |
Why?
|
| Psychometrics | 1 | 2007 | 137 | 0.070 |
Why?
|
| Certification | 1 | 2007 | 27 | 0.070 |
Why?
|
| Fatigue | 1 | 2007 | 85 | 0.070 |
Why?
|
| Insurance, Major Medical | 1 | 2006 | 1 | 0.070 |
Why?
|
| Demography | 1 | 2006 | 109 | 0.070 |
Why?
|
| Health Surveys | 1 | 2006 | 196 | 0.070 |
Why?
|
| Kansas | 1 | 2005 | 1 | 0.060 |
Why?
|
| Referral and Consultation | 1 | 2007 | 141 | 0.060 |
Why?
|
| Continental Population Groups | 1 | 2007 | 237 | 0.060 |
Why?
|
| Mental Disorders | 1 | 2006 | 121 | 0.060 |
Why?
|
| Mental Health | 2 | 2018 | 117 | 0.060 |
Why?
|
| Predictive Value of Tests | 1 | 2006 | 876 | 0.060 |
Why?
|
| Incidence | 1 | 2006 | 1199 | 0.050 |
Why?
|
| Survival Rate | 1 | 2005 | 877 | 0.050 |
Why?
|
| Radiography | 1 | 2003 | 376 | 0.050 |
Why?
|
| Reproducibility of Results | 2 | 2017 | 762 | 0.050 |
Why?
|
| Perception | 1 | 2002 | 98 | 0.050 |
Why?
|
| Iraq | 1 | 2020 | 2 | 0.050 |
Why?
|
| Afghanistan | 1 | 2020 | 6 | 0.050 |
Why?
|
| Breast Neoplasms | 1 | 2007 | 765 | 0.050 |
Why?
|
| Prevalence | 1 | 2003 | 981 | 0.040 |
Why?
|
| Cohort Studies | 1 | 2003 | 1817 | 0.040 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2002 | 353 | 0.040 |
Why?
|
| Arthritis | 1 | 2019 | 40 | 0.040 |
Why?
|
| Preoperative Period | 1 | 2017 | 35 | 0.040 |
Why?
|
| Factor Analysis, Statistical | 1 | 2017 | 77 | 0.040 |
Why?
|
| Postoperative Period | 1 | 2017 | 97 | 0.040 |
Why?
|
| Risk Factors | 1 | 2005 | 3876 | 0.040 |
Why?
|
| Recovery of Function | 1 | 2017 | 199 | 0.030 |
Why?
|
| Nursing Process | 1 | 2015 | 2 | 0.030 |
Why?
|
| Monitoring, Physiologic | 1 | 2015 | 73 | 0.030 |
Why?
|
| Affective Symptoms | 1 | 2014 | 16 | 0.030 |
Why?
|
| Postoperative Complications | 1 | 2019 | 780 | 0.030 |
Why?
|
| Combined Modality Therapy | 1 | 2015 | 560 | 0.030 |
Why?
|
| Anxiety | 1 | 2014 | 191 | 0.030 |
Why?
|
| Monitoring, Ambulatory | 1 | 2010 | 10 | 0.020 |
Why?
|
| Autoimmunity | 1 | 2007 | 32 | 0.020 |
Why?
|
| Geriatric Assessment | 1 | 2010 | 390 | 0.020 |
Why?
|
| Neoplasm Staging | 1 | 2007 | 447 | 0.020 |
Why?
|
| Aged, 80 and over | 1 | 2007 | 3990 | 0.010 |
Why?
|